Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82173668)
  • National Natural Science Foundation of China (82373706)

This publication has 47 references indexed in Scilit: